Cargando…
The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
BACKGROUND: The R47H variant of Triggering Receptor Expressed on Myeloid cells 2 (TREM2) confers greatly increased risk for Alzheimer’s disease (AD), reflective of a central role for myeloid cells in neurodegeneration. Understanding how this variant confers AD risk promises to provide important insi...
Autores principales: | Cheng-Hathaway, Paul J., Reed-Geaghan, Erin G., Jay, Taylor R., Casali, Brad T., Bemiller, Shane M., Puntambekar, Shweta S., von Saucken, Victoria E., Williams, Roxanne Y., Karlo, J. Colleen, Moutinho, Miguel, Xu, Guixiang, Ransohoff, Richard M., Lamb, Bruce T., Landreth, Gary E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984804/ https://www.ncbi.nlm.nih.gov/pubmed/29859094 http://dx.doi.org/10.1186/s13024-018-0262-8 |
Ejemplares similares
-
TREM2 in Neurodegenerative Diseases
por: Jay, Taylor R., et al.
Publicado: (2017) -
TREM2 deficiency eliminates TREM2(+) inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
por: Jay, Taylor R., et al.
Publicado: (2015) -
Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
por: Jadhav, Vaishnavi S., et al.
Publicado: (2020) -
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
por: Casali, Brad T., et al.
Publicado: (2018) -
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
por: Bemiller, Shane M., et al.
Publicado: (2017)